Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,815
archived clinical trials in
Parkinsons Disease

SAM-e for the Treatment of Depression in Patients With Parkinson's Disease
SAM-e Treatment of Depression in Parkinson's Disease
Status: Archived
New York University
mi
from
New York, NY
SAM-e for the Treatment of Depression in Patients With Parkinson's Disease
SAM-e Treatment of Depression in Parkinson's Disease
Status: Archived
Updated: 1/1/1970
New York University
mi
from
New York, NY
A Study of Neurophysiologic Changes in Individuals With Parkinson's Disease
Open-Label Validation Study of Neurophysiologic Changes in Individuals With Parkinson's Disease, at Risk for Parkinson's Disease and Healthy Controls
Status: Archived
The Institute for Neurodegenerative Disorders
mi
from
New Haven, CT
A Study of Neurophysiologic Changes in Individuals With Parkinson's Disease
Open-Label Validation Study of Neurophysiologic Changes in Individuals With Parkinson's Disease, at Risk for Parkinson's Disease and Healthy Controls
Status: Archived
Updated: 1/1/1970
The Institute for Neurodegenerative Disorders
mi
from
New Haven, CT
Telephone Call From Acute Care Physicians to Long Term Care Physicians: Impact on Transitional Care of Elderly Patients
Status: Archived
Maimonide Medical Center
mi
from
Brooklyn, NY
Telephone Call From Acute Care Physicians to Long Term Care Physicians: Impact on Transitional Care of Elderly Patients
Status: Archived
Updated: 1/1/1970
Maimonide Medical Center
mi
from
Brooklyn, NY
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Clinical Research Facility
mi
from
Birmingham, AL
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Birmingham, AL
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Clinical Research Facility
mi
from
Fountain Valley, CA
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Fountain Valley, CA
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Clinical Research Facility
mi
from
Irvine, CA
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Irvine, CA
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Clinical Research Facility
mi
from
Los Angeles, CA
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Los Angeles, CA
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Clinical Research Facility
mi
from
Oceanside, CA
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Oceanside, CA
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Clinical Research Facility
mi
from
Englewood, CO
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Englewood, CO
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Georgetown Univ Med Ctr
mi
from
Washington,
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Updated: 1/1/1970
Georgetown Univ Med Ctr
mi
from
Washington,
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Clinical Research Facility
mi
from
Bradenton, FL
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Bradenton, FL
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
University of Florida Gainesville
mi
from
Gainesville, FL
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Updated: 1/1/1970
University of Florida Gainesville
mi
from
Gainesville, FL
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Clinical Research Facility
mi
from
Jacksonville, FL
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Jacksonville, FL
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Clinical Research Facility
mi
from
Port Charlotte, FL
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Port Charlotte, FL
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Clinical Research Facility
mi
from
Tampa, FL
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Tampa, FL
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Clinical Research Facility
mi
from
Atlanta, GA
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Atlanta, GA
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Clinical Research Facility
mi
from
Augusta, GA
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Augusta, GA
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Clinical Research Facility
mi
from
Chicago, IL
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Chicago, IL
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Clinical Research Facility
mi
from
Chicago, IL
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Chicago, IL
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Clinical Research Facility
mi
from
Lexington, KY
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Lexington, KY
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Clinical Research Facility
mi
from
Louisville, KY
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Louisville, KY
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Clinical Research Facility
mi
from
Shreveport, LA
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Shreveport, LA
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Clinical Research Facility
mi
from
Baltimore, MD
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Baltimore, MD
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Clinical Research Facility
mi
from
Baltimore, MD
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Baltimore, MD
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Clinical Research Facility
mi
from
Boston, MA
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Boston, MA
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Clinical Research Facility
mi
from
St Louis, MO
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
St Louis, MO
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Clinical Research Facility
mi
from
Omaha, NE
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Omaha, NE
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Clinical Research Facility
mi
from
Albany, NY
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Albany, NY
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Clinical Research Facility
mi
from
Manhasset, NY
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Manhasset, NY
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Clinical Research Facility
mi
from
New York, NY
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
New York, NY
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Mount Sinai Hospital
mi
from
New York, NY
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Updated: 1/1/1970
Mount Sinai Hospital
mi
from
New York, NY
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Clinical Research Facility
mi
from
Charlotte, NC
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Charlotte, NC
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Clinical Research Facility
mi
from
Raleigh, NC
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Raleigh, NC
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Wake Forest University Baptist Medical Center
mi
from
Winston-Salem, NC
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Updated: 1/1/1970
Wake Forest University Baptist Medical Center
mi
from
Winston-Salem, NC
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Clinical Research Facility
mi
from
Cincinatti, OH
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Cincinatti, OH
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Clinical Research Facility
mi
from
Cleveland, OH
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Cleveland, OH
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Clinical Research Facility
mi
from
Indiana, PA
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Indiana, PA
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Clinical Research Facility
mi
from
Philadelphia, PA
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Philadelphia, PA
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Clinical Research Facility
mi
from
Philadelphia, PA
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Philadelphia, PA
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Clinical Research Facility
mi
from
Nashville, TN
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Nashville, TN
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Clinical Research Facility
mi
from
Houston, TX
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Houston, TX
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Fletcher Allen Health Care
mi
from
Burlington, VT
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Updated: 1/1/1970
Fletcher Allen Health Care
mi
from
Burlington, VT
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Clinical Research Facility
mi
from
Kirkland, WA
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Kirkland, WA
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Clinical Research Facility
mi
from
Marshfield, WI
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Marshfield, WI
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Clinical Research Facility
mi
from
Milwaukee, WI
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
An Open-Label, 12-Month Safety and Efficacy Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Subjects With Advanced Parkinson's Disease and Severe Motor-Fluctuations Despite Optimized Treatment With Available Parkinson's Disease Medications
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Milwaukee, WI
Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects
A Randomized, Double-Blind, Double-Dummy, Efficacy, Safety and Tolerability Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects Receiving Optimized Treatments With Parkinson Medicinal Products Who Continue to Experience Persistent Motor Fluctuations
Status: Archived
Clinical Research Facility
mi
from
Englewood, CO
Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects
A Randomized, Double-Blind, Double-Dummy, Efficacy, Safety and Tolerability Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects Receiving Optimized Treatments With Parkinson Medicinal Products Who Continue to Experience Persistent Motor Fluctuations
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Englewood, CO
Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects
A Randomized, Double-Blind, Double-Dummy, Efficacy, Safety and Tolerability Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects Receiving Optimized Treatments With Parkinson Medicinal Products Who Continue to Experience Persistent Motor Fluctuations
Status: Archived
Clinical Research Facility
mi
from
Washington,
Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects
A Randomized, Double-Blind, Double-Dummy, Efficacy, Safety and Tolerability Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects Receiving Optimized Treatments With Parkinson Medicinal Products Who Continue to Experience Persistent Motor Fluctuations
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Washington,
Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects
A Randomized, Double-Blind, Double-Dummy, Efficacy, Safety and Tolerability Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects Receiving Optimized Treatments With Parkinson Medicinal Products Who Continue to Experience Persistent Motor Fluctuations
Status: Archived
Clinical Research Facility
mi
from
Bradenton, FL
Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects
A Randomized, Double-Blind, Double-Dummy, Efficacy, Safety and Tolerability Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects Receiving Optimized Treatments With Parkinson Medicinal Products Who Continue to Experience Persistent Motor Fluctuations
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Bradenton, FL
Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects
A Randomized, Double-Blind, Double-Dummy, Efficacy, Safety and Tolerability Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects Receiving Optimized Treatments With Parkinson Medicinal Products Who Continue to Experience Persistent Motor Fluctuations
Status: Archived
Clinical Research Facility
mi
from
Gainesville, FL
Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects
A Randomized, Double-Blind, Double-Dummy, Efficacy, Safety and Tolerability Study of Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects Receiving Optimized Treatments With Parkinson Medicinal Products Who Continue to Experience Persistent Motor Fluctuations
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Gainesville, FL